These findings, especially in tandem with our recent companion paper (16), highlight a variety of potent therapeutic targets in the treatment of cystitis and provide further insight into the involvement of NGF signaling in sustained conditions of bladder inflammation. The gene discussed is NGF; the disease is chronic cystitis.